Gastrointestinal Bleeding Statistics & Rates

Gastrointestinal bleeding statistics and rates, or epidemiology, are pretty startling. Patients who are being treated with Pradaxa® (dabigatran) may want to compare the gastrointestinal bleeding risk figures for Pradaxa® patients with the GI bleeding risk figures for the general population. This is not an easy comparison, however.

Upper vs. Lower Gastrointestinal Bleeding Statistics

The statistics for gastrointestinal bleeds are usually classified into upper gastrointestinal tract bleeding statistics and lower gastrointestinal tract bleeding statistics, just like the symptoms themselves. Part of what makes it difficult to determine gastrointestinal bleeding rate is the fact that there are several ways to "divide" the gastrointestinal tract into the upper and lower tracts, and this makes it hard to compare upper and lower gastrointestinal bleed statistics (comparing both upper vs. lower, and comparing Pradaxa®-induced gastrointestinal bleeding vs. the rate for non-Pradaxa®-treated persons).

Nevertheless, some gastrointestinal bleeding statistics for the general population have been obtained; it's a good starting point. The statistics and rates in men and women have certainly been investigated. It turns out that men are more likely to develop gastrointestinal bleeding than women, for both upper and lower gastrointestinal bleeding.

Upper Gastrointestinal Bleeding Statistics

One study, conducted before Pradaxa® (dabigatran) was released on the U.S. market, found that when it comes to upper gastrointestinal tract (UGI) bleeding events recorded by healthcare practitioners in the U.S.:

  • there are approx. 100 hospitalizations per 100,000 persons per year
  • the risk of UGI events increases with age
  • the rate of UGI events is greater in males than in females
  • the mortality (death) rate for upper gastrointestinal events is 7–14 percent

Lower Gastrointestinal Bleeding Statistics

The same study found that for lower gastrointestinal tract (LGI) bleeding events:

  • there are approx. 21 hospitalizations per 100,000 persons per year
  • the risk of UGI events increases with age
  • the rate of UGI events is greater in males than in females
  • the mortality (death) rate for upper gastrointestinal events is 4 percent

Learn More About Gastrointestinal Bleeding Statistics

You can learn more about gastrointestinal bleeding statistics by speaking with your doctor. If you have suffered from a bleeding event that is suspected to have been caused by Pradaxa®, you may be eligible to recover financial compensation for your suffering. To learn more, contact our Pradaxa® attorneys today.

Get Help Today Schedule a free and confidential case review today.
* is a required field Attorney Advertising:
Flood Law Group LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004

Pradaxa® Injury Lawsuit Blog

FDA Issues Pradaxa® Safety Communication, Fails to Recognize No Reversal Agent

Posted on November 2nd, 2012 by Sarah O'Hara

"Pradaxa® provides an important health benefit when used as directed," the FDA said in the safety communication. "Healthcare professionals who... read more

Pradaxa® Bleeding Events Continue to Occur with No Antidote

Posted on October 4th, 2012 by Sarah O'Hara

According to reports, the number of bleeding events experienced by people taking Pradaxa® continues to rise even though there is no... read more

How to Choose the Right Attorney for your Pradaxa® Lawsuit

Posted on September 25th, 2012 by Sarah O'Hara

How to Choose the Right Attorney for your Pradaxa® Lawsuit
If you are taking the anticoagulant medication Pradaxa®, chances are you've already... read more

FDA Drug Recalls &
Safety Alerts

image description